Official name
Amanat Holdings
DFM · AMANAT

Amanat Holdings · What the issuer can provide
Coverage follows a reconciled listed-security identity and dated evidence. Inclusion describes research scope only; it is not a ranking, recommendation or claim of complete financial coverage.
Open a card to inspect its public evidence. Missing, stale, conflicting or unavailable data is never replaced with an estimate.
Identity-only public coverage; no completed research review is claimed.Revalidation is due; the dated record is not proof of current listing status.
Checked: 2026-08-11→AvailableVerified public issuer fields are available.
→Available3 source documents are linked to public facts.
→MissingNo linked activity currently passes every public source-document check.
→AvailableA rights-reviewed official identity source is linked.
→The fields below come from the current public company registry and any human-published issuer profile. Empty issuer-contact fields stay visibly missing until source and publication-rights review are complete.
Only exact-security, human-published activity that passes every public source-document check can appear here.
No linked update currently passes every public gate.
Open the full chronologyRequired identity fields are shown individually with their evidence state. A public link is not reuse permission, and a blank is never converted to a guess.
Amanat Holdings
AMANAT
DFM · XDFM
AEA005901011
Listed equity
Financial services and insurance · Healthcare and education operating investment holding
Primary active route confirmed
Not available in the public evidence layer
Not available in the public evidence layer
Not available in the public evidence layer
Not available in the public evidence layer
Not available in the public evidence layer
Not available in the public evidence layer
A verified public issuer profile has not been published yet.
GCC healthcare and education operating holding. Healthcare platform Cambridge Health Group provides post-acute rehabilitation, long-term care and home healthcare in the UAE and Saudi Arabia. Education platform Almasar includes Middlesex University Dubai, Saudi special-education operator Human Development Company and an equity-accounted interest in NEMA.
Amanat Holdings is a Gulf healthcare and education operator rather than a passive fund. Its healthcare engine, Cambridge Health Group, runs six hospitals plus a home-care platform covering post-acute rehabilitation and long-term care in the Emirates and Saudi Arabia; the 100% acquisition of that group completed in June 2026. Education sits inside Almasar, itself listed in Saudi Arabia and 70%-owned, which controls Middlesex University Dubai, holds 60% of Human Development Company and accounts for a 35% interest in NEMA under the equity method.
First-quarter 2026 healthcare reporting showed 715 total beds, 666 licensed beds and an average inpatient census of 530, with revenue of AED112.9m, operating earnings of AED28.6m and net profit of AED13.8m. Jeddah had 70 beds under development and Khobar 101 licensed beds with a further 49 awaiting licence. Education delivered AED185.6m of revenue and AED62.3m of net profit across roughly 28.6 thousand students and beneficiaries in 59 facilities, with 15 more being built; international students were 54% of the Middlesex body.
FY2025 cash stood at AED1.450bn against bank financing of AED336.164m, but that balance sits inside operating subsidiaries and inside 70%-owned Almasar. Debt packages carry company and subsidiary guarantees, pledges over subsidiary shares, a Saudi dividend assignment and security over property and receivables. Goodwill and intangibles of AED1.384bn represented 30.22% of assets, and management's sensitivity showed a 5% patient decline at Sukoon would trigger AED39m of impairment.
Continuing revenue grew from AED412.872m in FY2021 to AED931.689m in FY2025, but the perimeter changed through disposals, the Almasar listing and a discontinued operation, so no organic growth rate is implied. Gross trade receivables rose 32.27% to AED357.670m while continuing revenue rose 17.03%; the expected-loss allowance was 13.51%. One Human Development Company customer represented 46% of gross group receivables and two healthcare payers 54%. Quarterly operating cash flow was negative AED36.756m.
The verified set carries no parent-only cash, debt and guarantee bridge after the Cambridge purchase, no covenant or value-in-use headroom, no post-quarter collection data and no look-through net asset build-up for Almasar and NEMA. Six holders above 5% own 63.12% between them, and the residual is not demonstrated to be tradable. This review assigns no valuation and no trade.
A financial institution can earn from lending or financing, exchange, brokerage, asset management, investment holdings, transaction fees or capital markets. Each activity carries a different balance-sheet and regulatory perimeter.
Identify the exact fee, spread, asset, transaction or investment exposure creating income.
Separate client activity, assets under management and proprietary balance-sheet exposure.
Reconcile recurring fees and spreads with fair-value, realised and one-off gains.
Trace liquidity, receivables, client money, funding, leverage and regulatory capital.
Read growth against licences, risk limits, capital needs and the exact legal entity.
A manually reviewed, paraphrased snapshot from issuer and official market records. Each field keeps its exact source and verification date.
Official website, investor-relations, market-record and public contact fields remain unavailable here until their exact source, current value and reuse boundary are reviewed. Nothing is inferred from aggregators or another company.
The metrics below define the correct analytical lens for this business model. They contain no company values: a value appears only after official-document provenance and editorial verification.
Only exact-security activity that passes the automatic source, locator, date and localization gates is shown. Exceptions remain unpublished. Each date keeps its lifecycle meaning.
No linked activity currently passes every public source-document check.
This company appears in the dated public collections below. Membership describes coverage and evidence context; it is not a ranking or recommendation.
Public profiles with canonical exchange DFM.
Public profiles with a complete source-linked review currently visible to every reader.
Dated public identity checks earlier than 18 August 2026; this does not assert current listing status.
Open this company's free source-linked fundamental-review preview or compare coverage packs and ongoing monitoring. Coverage is not an investment ranking.